As the global AI race heated up last month with the launch of DeepSeek R1 and Alibaba’s Qwen 2.5 AI models, US AI firms are ...

TD Cowen raised the firm’s price target on Boston Scientific (BSX) to $115 from $110 and keeps a Buy rating on the shares. The firm expects ...

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Boston Scientific (BSX) to $115 from $95 and keeps an Overweight rating on ...

Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that ...

The upcoming report from Boston Scientific (BSX) is expected to reveal quarterly earnings of $0.65 per share, indicating an increase of 18.2% compared to the year-ago period. Analysts forecast ...

JetBlue is adding four new domestic and three international destinations to its schedule for summer flights departing from Boston Logan International Airport.The airline boasts that the seasonal ...

TOKYO -- A disreputable scientific journal used generative AI to create bogus papers, using the names of three Japanese researchers without permission in what is thought to be an instance of ...

I’m still a believer in the story at Boston Scientific, but the valuation situation remains challenging. I do think there’s a credible chance of BSX generating 10% long-term revenue growth and ...

As the political relationship between the United States and China has frayed, the scientific ties between them have become thinner and more fragile. This is a dangerous trend. Working together ...

The Farapulse (left) and Watchman FLX Pro (right) systems. [Images courtesy of Boston Scientific] Boston Scientific (NYSE: BSX) + CEO Mike Mahoney expects more growth for the company in 2025.